This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biogen Ma Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: George Campbell Kaynor: Innovator in JC Virus Research
Introduction
George Campbell Kaynor is a notable inventor based in Melrose, MA (US). He has made significant contributions to the field of medical research, particularly in the development of neutralizing antibodies against the JC virus.
Latest Patents
Kaynor holds a patent for JCV neutralizing antibodies. This patent provides methods for the treatment of progressive multifocal leukoencephalopathy (PML). The invention includes an isolated JC-virus neutralizing monoclonal antibody against the JCV capsid protein VP1 (JCV-VP1). The antibody is designed to suppress the infectivity of the JC virus. It binds to the sialic acid binding pocket of JCV-VP1 and can include various mutations such as S269F, S269Y, S267F, N265D, Q271H, D66H, K60E, K60N, and L55F.
Career Highlights
Kaynor is associated with Biogen MA Inc., where he continues to advance his research in virology and antibody development. His work has the potential to impact the treatment of viral infections significantly.
Collaborations
Kaynor collaborates with notable colleagues, including Kenneth J. Simon and Mia Marie Rushe, who contribute to his research endeavors.
Conclusion
George Campbell Kaynor's innovative work in developing neutralizing antibodies against the JC virus showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against viral diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile